UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
'Korea needs to designate birth control pills as over-the-counter drugs'
A Health Insurance Review & Assessment Service report has shown that hospit...
by Lee Han-soo
|
2019-10-22 19:43
라인
Celltrion unveils clinical results of Remsima SC in treating IBD
Celltrion said that is has presented the phase 1, part 2 trial results for ...
by Lee Han-soo
|
2019-10-22 17:00
라인
‘Oral drugs as effective as inhalers for elderly with asthma’
Physicians generally recommend inhaled corticosteroids as the first drug fo...
by Jeong Sae-im
|
2019-10-22 15:48
라인
KUGH’s emergency treatment system saved Frenchman
Korea University Guro Hospital (KUGH) said that its emergency medical syste...
by Lee Han-soo
|
2019-10-22 15:45
라인
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
Pfizer recently proved the efficacy of its investigational atopic dermatiti...
by Kim Yun-mi
|
2019-10-22 14:17
라인
Biogen, Samsung Bioepis to present biosimilar data at EU conference
Biogen and Samsung Bioepis said that they plan to present new real-world da...
by Lee Han-soo
|
2019-10-22 11:31
라인
Vuno, EU to develop AI software that predicts antidepressant efficacy
Vuno said that it would develop DEPREDICT, an artificial intelligence softw...
by Lee Han-soo
|
2019-10-22 11:31
라인
Pharma industry hits government steps regarding ranitidine ban
The local pharmaceutical industry is expressing its distrust and displeasur...
by Lee Han-soo
|
2019-10-21 17:16
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutic...
by Jeong Sae-im
|
2019-10-21 16:42
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
GSK said that it has applied to obtain an additional indication for Trelegy...
by Lee Han-soo
|
2019-10-21 15:32
라인
‘Korea’s ultra-low birthrate needs state of emergency declaration’
A lawmaker criticized the government’s naïve response to the nation’s ...
by Choi Gwang-seok
|
2019-10-21 15:29
라인
Korea University Medicine to supply public healthcare service to Uzbekistan
Korea University Medicine (KUM) said that it would develop and supply the K...
by Lee Han-soo
|
2019-10-21 14:24
라인
Drug firms’ Q3 earnings to be fairly good
Korea’s large pharmaceutical companies are expected to have yielded good ea...
by Jeong Sae-im
|
2019-10-21 12:27
라인
Regulator OKs Jeil's advanced colorectal cancer treatment
Jeil Pharmaceutical said that the Ministry of Food and Drug Safety has appr...
by Lee Han-soo
|
2019-10-21 11:38
라인
‘Government says one thing, does another on bio-health industry promotion’
President Moon Jae-in has pledged to foster the bio-health industry as a ma...
by Lee Han-soo
|
2019-10-21 11:38
라인
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo
|
2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo
|
2019-10-18 16:48
라인
Medytox exported ₩3.3 billion worth of unqualified BTX
The Ministry of Food and Drug Safety ordered Medytox to recall and discard ...
by Jeong Sae-im
|
2019-10-18 16:02
라인
Daewoong launches BTX in Canada
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX)...
by Lee Han-soo
|
2019-10-18 14:31
라인
Korea still has highest TB incidence, mortality in OECD
Despite the government’s anti-tuberculosis efforts, Korea still suffered th...
by Kwak Sung-sun
|
2019-10-18 14:31
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top